1. Home
  2. PED vs CELU Comparison

PED vs CELU Comparison

Compare PED & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

N/A

Current Price

$0.68

Market Cap

56.7M

Sector

Energy

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.32

Market Cap

34.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PED
CELU
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
34.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
PED
CELU
Price
$0.68
$1.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$1.50
$6.00
AVG Volume (30 Days)
560.8K
28.0K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,553,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$305.89
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
28.49
N/A
52 Week Low
$0.43
$1.01
52 Week High
$0.82
$4.35

Technical Indicators

Market Signals
Indicator
PED
CELU
Relative Strength Index (RSI) 53.32 57.21
Support Level $0.57 $1.21
Resistance Level $0.82 $1.51
Average True Range (ATR) 0.06 0.12
MACD 0.01 0.01
Stochastic Oscillator 35.07 69.75

Price Performance

Historical Comparison
PED
CELU

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: